By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bayer HealthCare 

77 Belfield Road

Toronto  Ontario  M9W 1G6  Canada
Phone: 416-248-0771 Fax: 800-622-2937


SEARCH JOBS








Company News
FDA Approves Bayer HealthCare (BAY)'s Finacea (Azelaic Acid) Foam, 15% For The Topical Treatment Of The Inflammatory Papules And Pustules Of Mild To Moderate Rosacea 7/31/2015 11:14:50 AM
Bayer HealthCare (BAY) and Foamix Pharmaceuticals, Ltd. (FOMX) Release: Finacea (Azelaic Acid) Foam 15%, Approved By U.S. FDA For Topical Treatment Of The Inflammatory Papules And Pustules Of Mild To Moderate Rosacea 7/31/2015 7:53:51 AM
Sprint Bioscience Enters Into Collaboration With Bayer HealthCare (BAY) On Tumor Metabolism Program 7/28/2015 10:54:11 AM
Bayer HealthCare (BAY) And Johns Hopkins University Collaborate To Develop New Ophthalmic Therapies 6/16/2015 8:55:31 AM
Bayer HealthCare (BAY) Release: New Data Show Need For Improved Monitoring For Pulmonary Hypertension Following Pulmonary Embolism 5/20/2015 6:51:43 AM
Bayer HealthCare (BAY) Licenses Investigational ISIS FXI(Rx) From Isis Pharma (ISIS) To Develop And Commercialize For The Prevention Of Thrombosis 5/4/2015 8:57:41 AM
Bayer HealthCare (BAY) Release: Five-Year Follow-Up Study Further Supports Effectiveness And Safety Of The Essure Procedure As A Non-Surgical, Non-Hormonal Option For Permanent Contraception 5/1/2015 8:37:02 AM
Fifth Death Tied to Bayer HealthCare (BAY)'s Controversial Birth Control Device 4/28/2015 7:17:01 AM
Bayer HealthCare (BAY) to Shutter Kansas Plant, 130 Jobs Terminated 4/23/2015 6:10:22 AM
Bayer HealthCare (BAY) Release: FDA Accepts Filing Of BETACONNECT For Relapsing-Remitting Multiple Sclerosis Patients Taking BETASERON (interferon beta-1b) 4/22/2015 11:33:31 AM
12345678910...
//-->